MCLAREN NORTHERN MICHIGAN — History
CCN 230105 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$235M
Latest Revenue (FY2022)
+1.5%
Revenue CAGR (3yr)
-0.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $228M | $249M | $235M | -5.5% | +1.5% |
| Operating Expenses | $242M | $226M | $236M | +4.8% | -1.2% |
| Operating Margin | -6.2% | 9.3% | -0.6% | -106.5% | +0.0% |
| Net Income | $-14M | $23M | $-1M | -106.1% | +0.0% |
| Licensed Beds | 170 | 172 | 177 | +2.9% | +2.0% |
| Total Patient Days | 32,349 | 33,550 | 32,300 | -3.7% | -0.1% |
| Medicare Day % | 43% | 37% | 35% | -7.6% | -10.5% |
| Medicaid Day % | 5% | 3% | 6% | +87.7% | +10.7% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +3.1% ($228M → $235M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.5%
This Hospital
+7.6%
State Avg
Latest Margin
-0.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $238M | 2.2% |
| FY2024 (proj) | $242M | 5.0% |
| FY2025 (proj) | $245M | 7.7% |